메뉴 건너뛰기
Clinical Trials
Volumn 8, Issue 3, 2011, Pages 270-276
Alternatives to the standard Fleming, Harrington, and O'Brien futility boundary
Author keywords

[No Author keywords available]
Indexed keywords

ARTICLE; FLEMING, HARRINGTON, AND O'BRIEN BOUNDARY; INFORMATION PROCESSING; METHODOLOGY; NULL HYPOTHESIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIMULATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;
EID: 79960274616     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774511401636     Document Type: Article
Times cited : (18)
References (12)
  • 1
    • 0027934302 scopus 로고
    • Interim analysis: The alpha spending function approach
    • DeMets DL, Lan KKG. Interim analysis: the alpha spending function approach. Stat Med. 1994 ; 113: 1341-52 (Pubitemid 24236184)
    • (1994) Statistics in Medicine , vol.13 , Issue.13-14 , pp. 1341-1352
    • DeMets, D.L.1    Lan, K.K.G.2
  • 2
    • 0018687930 scopus 로고
    • A multiple testing procedure for clinical trials
    • DOI 10.2307/2530245
    • O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979 ; 35: 549-56 (Pubitemid 10242750)
    • (1979) Biometrics , vol.35 , Issue.3 , pp. 549-556
    • O'Brien, P.C.1    Fleming, T.R.2
  • 3
    • 0002296743 scopus 로고
    • Group sequential designs for one-sided and two-sided hypotheses with provision for early stopping in favor of the null hypotheses
    • Pampallona S, Tsiatis AA. Group sequential designs for one-sided and two-sided hypotheses with provision for early stopping in favor of the null hypotheses. J Statist Plann Inference. 1994 ; 42: 19-35
    • (1994) J Statist Plann Inference , vol.42 , pp. 19-35
    • Pampallona, S.1    Tsiatis, A.A.2
  • 4
    • 84953030627 scopus 로고
    • Stochastically curtailed tests in long-term clinical trials
    • Lan KKG, Simon R, Halperin M. Stochastically curtailed tests in long-term clinical trials. Commun Statist C. 1982 ; 1: 207-19
    • (1982) Commun Statist C , vol.1 , pp. 207-19
    • Lan, K.K.G.1    Simon, R.2    Halperin, M.3
  • 5
    • 0023677293 scopus 로고
    • The B-value: A tool for data monitoring
    • Lan KKG, Wittes J. The B-value: a tool for data monitoring. Biometrics. 1988 ; 44: 579-85
    • (1988) Biometrics , vol.44 , pp. 579-85
    • Lan, K.K.G.1    Wittes, J.2
  • 7
    • 0036343996 scopus 로고    scopus 로고
    • A comment on futility monitoring
    • DOI 10.1016/S0197-2456(02)00218-0, PII S0197245602002180
    • Freidlin B, Korn EL. A comment on futility monitoring. Control Clin Trials. 2002 ; 23: 355-66 (Pubitemid 34874888)
    • (2002) Controlled Clinical Trials , vol.23 , Issue.4 , pp. 355-366
    • Freidlin, B.1    Korn, E.L.2
  • 8
    • 0021829517 scopus 로고
    • An efficient design for phase III studies of combination chemotherapies
    • Ellenberg SS, Eisenberger MA. An efficient design for phase III studies of combination chemotherapies. Cancer Treat Rep. 1985 ; 69: 1147-52 (Pubitemid 15249126)
    • (1985) Cancer Treatment Reports , vol.69 , Issue.10 , pp. 1147-1152
    • Ellenberg, S.S.1    Eisenberger, M.A.2
  • 9
    • 0027980912 scopus 로고
    • Stopping when the experimental regimen does not appear to help
    • Weiand S, Schroeder G, O'Fallon JR. Stopping when the experimental regimen does not appear to help. Stat Med. 1994 ; 13: 1453-58 (Pubitemid 24236197)
    • (1994) Statistics in Medicine , vol.13 , Issue.13-14 , pp. 1453-1458
    • Wieand, S.1    Schroeder, G.2    O'Fallon, J.R.3
  • 10
    • 53149129878 scopus 로고    scopus 로고
    • Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group
    • O'Leary M, Krailo M, Anderson JR, Reaman GH. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group. Semin Oncol. 2008 ; 35: 484-93
    • (2008) Semin Oncol , vol.35 , pp. 484-93
    • O'Leary, M.1    Krailo, M.2    Anderson, J.R.3    Reaman, G.H.4
  • 11
    • 70449698239 scopus 로고    scopus 로고
    • Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group study D9803
    • Arndt CA, Stoner JA, Hawkins DS, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group study D9803. J Clin Oncol. 2009 ; 27: 5182-88
    • (2009) J Clin Oncol , vol.27 , pp. 5182-88
    • Arndt, C.A.1    Stoner, J.A.2    Hawkins, D.S.3
  • 12
    • 77952760568 scopus 로고    scopus 로고
    • A general inefficacy interim monitoring rule for randomized clinical trials
    • Freidlin B, Korn EL, Gray R. A general inefficacy interim monitoring rule for randomized clinical trials. Clin Trials. 2010 ; 7: 197-208
    • (2010) Clin Trials , vol.7 , pp. 197-208
    • Freidlin, B.1    Korn, E.L.2    Gray, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.